The relationship between Zinc and Osteoporosis is moderately strong. Zinc ranks 17 of 471 Osteoporosis treatments on our list.


Osteoporosis ("porous bones", from Greek: οστούν/ostoun meaning "bone" and πόρος/poros meaning "pore") is a progressive bone disease that is characterised by a decrease in bone mass and density and that leads to an increased risk of fracture.

Zinc, in commerce also spelter, is a metallic chemical element; it has the symbol Zn and atomic number 30.

Strength of evidence

Zinc for Osteoporosis ranks in the top 57% of condition-treatment relationships we analyzed. (Higher number, stronger evidence.)

We found 41 studies on people and 38 studies on animals. Importantly, we found only 1 study that was randomized and controlled. Such studies are considered the most rigorous, and help to establish or disprove a cause-and-effect relationship between prospective treatments and conditions. So there may be some good evidence on which to make a decision about using this treatment.

How it compares

Here's how Zinc compares to other Osteoporosis treatments we analyzed, as well as to all condition-treatment relationships:

Amount of research

The relationship between Osteoporosis and Zinc has been little researched. We found at least 257 research articles on the topic. This places the volume of research in the bottom 17% of relationships we have analyzed between treatments and conditions.

Research trends

Are researchers becoming more or less interested in Zinc for Osteoporosis? The pace of research appears to be increasing:

Important caveat—help improve this information

Please note that our analysis is automated and imperfect. If you have personal insight, please help improve our analysis by rating this relationship and the research supporting it. And check back regularly; we last analyzed research for this relationship on Mar 13, 2014, and are constantly updating our database and algorithms.

Related links


Rate this treatment
for Osteoporosis

Top treatments
for Osteoporosis